Palisade Bio Surges Over 100 % on Positive Preclinical Data
Palisade Bio Inc, a dedicated biopharmaceutical company committed to pioneering therapeutics for serious chronic gastrointestinal (GI) diseases, has witnessed a remarkable upswing in its stock
